InvestSMART

Neurizon Therapeutics Limited (ASX: NUZ) - Announcements

- Current share price for NUZ : $0.077

ASX company news and announcements for Neurizon Therapeutics Limited (NUZ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurizon Therapeutics Limited (NUZ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurizon Therapeutics Limited (NUZ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurizon Therapeutics Limited (NUZ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$61 Notification of cessation of securities - NUZ 6 Jan 2026 10:36AM $0.079 $0.077 fallen by 2.53%
$61 Entitlement Offer Opens & Despatch of Offer Booklet 5 Jan 2026 8:54AM $0.082 $0.077 fallen by 6.10%
$61 Section 708A Cleansing Statement 2 Jan 2026 9:32AM $0.085 $0.077 fallen by 9.41%
$61 Regulatory and Development Update 2 Jan 2026 8:47AM $0.085 $0.077 fallen by 9.41%
$61 Change of Director's Interest Notices x4 2 Jan 2026 8:28AM $0.085 $0.077 fallen by 9.41%
$61 Application for quotation of securities - NUZ 31 Dec 2025 10:52AM $0.081 $0.077 fallen by 4.94%
$61 Section 708A Cleansing Statement 23 Dec 2025 12:58PM $0.086 $0.077 fallen by 10.47%
$61 Application for quotation of securities - NUZ 23 Dec 2025 11:51AM $0.088 $0.077 fallen by 12.50%
$61 Notice under s708AA(2)(f) 23 Dec 2025 9:51AM $0.110 $0.077 fallen by 30%
$61 Proposed issue of securities - NUZ 23 Dec 2025 9:51AM $0.110 $0.077 fallen by 30%
$61 Proposed issue of securities - NUZ 23 Dec 2025 9:50AM $0.110 $0.077 fallen by 30%
$61 Equity Raising Presentation 23 Dec 2025 9:50AM $0.110 $0.077 fallen by 30%
$61 New Funding Secured for HEALEY ALS Platform Trial 23 Dec 2025 9:49AM $0.110 $0.077 fallen by 30%
$61 Trading Halt 19 Dec 2025 9:13AM $0.110 $0.077 fallen by 30%
$61 FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial 11 Dec 2025 8:27AM $0.115 $0.077 fallen by 33.04%
$61 Neurizon Completes GMP Tablet Registration Batches 4 Dec 2025 8:54AM $0.105 $0.077 fallen by 26.67%
$61 Amended Constitution 3 Dec 2025 2:35PM $0.105 $0.077 fallen by 26.67%
$61 Results of Annual General Meeting 26 Nov 2025 7:05PM $0.105 $0.077 fallen by 26.67%
$61 AGM Presentation 26 Nov 2025 2:51PM $0.105 $0.077 fallen by 26.67%
$61 Chairman's AGM Address 26 Nov 2025 2:49PM $0.105 $0.077 fallen by 26.67%
$61 Elanco executive appointed as Board Observer 26 Nov 2025 9:16AM $0.110 $0.077 fallen by 30%
$61 Section 708A Cleansing Statement 31 Oct 2025 3:27PM $0.118 $0.077 fallen by 34.47%
$61 Application for quotation of securities - NUZ 31 Oct 2025 3:17PM $0.118 $0.077 fallen by 34.47%
$61 Neurizon to present Q1 FY2026 Results 31 Oct 2025 9:35AM $0.110 $0.077 fallen by 30%
$61 Appendix 4C & Quarterly Update 29 Oct 2025 9:42AM $0.125 $0.077 fallen by 38.40%

76 - 100 of 184 results

Page 4 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.